Liquids / Suspensions

LGM Pharma Handles Non-Sterile Liquid Dosage Forms for Oral, Nasal, and Ophthalmic Uses

Masters of cough and cold formulations, LGM Pharma can manufacture your liquids and suspensions

LGM Pharma’s 54,000-square-foot liquid and semi-solid GMP manufacturing facility in Rosenberg, Texas is known for producing reliably high-quality cough and cold branded and generic formulations – nearly 10 million bottles annually. We’re ready to produce any non-sterile liquid solution you need, from clinical to commercial batches. The Rosenberg campus features analytical testing and quality and microbiology labs for in-house testing of all raw materials and manufactured products. This makes LGM Pharma a true turn-key CDMO partner for pharmaceutical sponsors looking to reshore liquid dosage forms or reformulate, for example, under the 505(b)(2) pathway.

Specialists in Non-Sterile Solutions, Suspension, and Syrups

Trust LGM to manufacture all types of liquid dosage pharmaceuticals:

  • Solutions, suspensions, syrups
  • Oral, nasal, ophthalmic, and optic applications
    • Controlled substances (DEA Class II-V)
  • Generic and innovator
  • Prescription and over-the-counter
  • Flexible batch size
    • Small, medium, or large clinical and commercial batches
    • Typical commercial batch sizes of 500-12,000 Liters
  • Finished liquid dose packaging

Quality is part of the solution

As your contract partner, we’re making sure your formulation is precisely manufactured, with documentation to support your FDA submission or prove ongoing post-market compliance. Our knowledgeable staff employs Quality by Design principles to establish and validate manufacturing processes and protocols that deliver a reproducibly safe, efficacious, and stable finished drug product. Quality is built into everything we do at LGM Pharma.

Full-Service Capabilities

From securing high-quality active pharmaceutical ingredients (API) to manufacturing finished drug product, LGM Pharma can bring your non-sterile liquid formulations to market. In-house analytical testing services — from method development to stability studies — are also part of your CDMO engagement. End-to-end capabilities in our U.S.-based facilities is particularly valuable if you’re looking to reshore your drug manufacturing or to reformulate under the accelerated 505(b)(2) pathway.

Partner Smart

Unique Outsourcing Models

At LGM Pharma, you’re more than a customer. We’re partners – and successful partnerships have “win-win” outcomes. That’s why we offer standard fee-for-service packages, joint-venture partnerships, and risk/profit-sharing models.

Explore Partnership Models